Loading...
Myelodysplastic syndromes current treatment algorithm 2018
Myelodysplastic syndromes (MDS) include a group of clonal myeloid neoplasms characterized by cytopenias due to ineffective hematopoiesis, abnormal blood and marrow cell morphology, and a risk of clonal evolution and progression to acute myeloid leukemia (AML). Because outcomes for patients with MDS...
Na minha lista:
| Udgivet i: | Blood Cancer J |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5967332/ https://ncbi.nlm.nih.gov/pubmed/29795386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0085-4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|